Healthcare provider profile · identity verified

Jason Christopher Mccarthy, M.D.

Family Practice · BELLEVILLE, IL · NPI 1962605782

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	740	244
Amlodipine Besylate	Amlodipine Besylate	425	148
Levothyroxine Sodium	Levothyroxine Sodium	286	79
Lisinopril	Lisinopril	270	93
Tamsulosin Hcl	Tamsulosin Hcl	197	69
Losartan Potassium	Losartan Potassium	188	68
Albuterol Sulfate Hfa	Albuterol Sulfate	176	87
Fluticasone Propionate	Fluticasone Propionate	161	72
Ipratropium Bromide	Ipratropium Bromide	146	119
Duloxetine Hcl	Duloxetine Hcl	138	54
Metoprolol Succinate	Metoprolol Succinate	126	40
Famotidine	Famotidine	125	50
Gabapentin	Gabapentin	118	43
Pantoprazole Sodium	Pantoprazole Sodium	118	50
Hydrochlorothiazide	Hydrochlorothiazide	115	42
Metformin Hcl Er	Metformin Hcl	103	45
Rosuvastatin Calcium	Rosuvastatin Calcium	95	35
Metoprolol Tartrate	Metoprolol Tartrate	90	34
Trazodone Hcl	Trazodone Hcl	90	40
Alvesco	Ciclesonide	85	28
Alendronate Sodium	Alendronate Sodium	84	36
Jardiance	Empagliflozin	84	29
Sertraline Hcl	Sertraline Hcl	75	26
Simvastatin	Simvastatin	73	24
Finasteride	Finasteride	71	26
Allopurinol	Allopurinol	67	21
Metformin Hcl	Metformin Hcl	65	24
Furosemide	Furosemide	59	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	20
Clopidogrel	Clopidogrel Bisulfate	54	20
Carvedilol	Carvedilol	49	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	43
Glipizide	Glipizide	47	16
Lidocaine	Lidocaine	43	29
Ozempic	Semaglutide	42	13
Paxlovid	Nirmatrelvir/Ritonavir	41	41
Atenolol	Atenolol	39	16
Cefadroxil	Cefadroxil	39	37
Montelukast Sodium	Montelukast Sodium	39	16
Glipizide Er	Glipizide	38	14
Wixela Inhub	Fluticasone Propion/Salmeterol	38	12
Lovastatin	Lovastatin	36	14
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	36	15
Bupropion Xl	Bupropion Hcl	35	18
Pradaxa	Dabigatran Etexilate Mesylate	35	suppressed
Breyna	Budesonide/Formoterol Fumarate	33	21
Spironolactone	Spironolactone	33	14
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	31	11
Chlorthalidone	Chlorthalidone	28	suppressed
Acyclovir	Acyclovir	27	11
Humulin N Kwikpen	Insulin Nph Human Isophane	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Humulin N	Insulin Nph Human Isophane	26	suppressed
Omeprazole	Omeprazole	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	19
Digoxin	Digoxin	23	suppressed
Mirtazapine	Mirtazapine	23	11
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	17	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	16
Memantine Hcl	Memantine Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Fluocinonide	Fluocinonide	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Victoza 2-Pak	Liraglutide	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error